Pharmaceutical Industry

Carlyle will pick up a 20 per cent stake for $490 million or around Rs 3,700 crore in the pharma subsidiary called Piramal Pharma Ltd

Updated On: 28 Jun 2020 | 12:24 AM IST

In 2018-19, India imported auto components worth $17.6 billion, of which 27 per cent -- $4.75 billion -- were from China

Updated On: 26 Jun 2020 | 5:01 PM IST

This is the first phytopharmaceutical drug (plant based) that the country's drug regulator has approved for clinical trials for Covid-19.

Updated On: 05 Jun 2020 | 10:38 PM IST

Remdesivir is the only drug so far that has been shown to help patients with Covid-19, but Gilead and other companies are looking for ways to make it work better.

Updated On: 02 Jun 2020 | 10:49 PM IST

Talks are still in advanced stage with KKR, say bankers

Updated On: 04 May 2020 | 11:24 PM IST

These drugs are in addition to the requirement to hydroxychloroquine and Azithromycin for patients, healthcare workers and household contacts of positive cases

Updated On: 18 Apr 2020 | 3:07 AM IST

Sensing serious health risks, the government has swung into action. Dispensing of these medicines would get stricter and states have started collecting information on available stock in the market

Updated On: 09 Apr 2020 | 7:26 AM IST

The health ministry invoked section 26B of the Drugs and Cosmetics Act, 1940 to facilitate the doorstep delivery of drugs to consumers

Updated On: 26 Mar 2020 | 11:46 PM IST

State has reported 15 positive Coronavirus cases so far

Updated On: 24 Mar 2020 | 7:11 PM IST

The global death toll has risen to over 9,000 with more than 217,000 confirmed infections, according to an AFP tally based on official sources.

Updated On: 20 Mar 2020 | 3:15 AM IST

Book review of PHARMA: Greed, Lies, and the Poisoning of America

Updated On: 15 Mar 2020 | 11:25 PM IST

The near-term worry for the company is the ongoing investigation by the US Department of Justice related to price fixing and cartelisation by generic companies

Updated On: 12 Mar 2020 | 2:09 AM IST

The Pharmexcil came up with clarifications for its members and representations to the government highlighting some difficulties

Updated On: 09 Mar 2020 | 12:17 AM IST

On the sidelines of an annual event of the Indian Drug Manufacturers' Association, a senior government official said plans had been readied in this regard

Updated On: 20 Jan 2020 | 9:20 PM IST

That is above the average of 404 drug price increases in the first three days of January over the past five years

Updated On: 04 Jan 2020 | 8:09 PM IST

Putting aside prices for a moment, it's been an exciting period for medical progress

Updated On: 25 Dec 2019 | 8:21 AM IST

Aurobindo Pharma on Thursday said its subsidiary Auro Vaccines LLC has entered into a pact to acquire certain business assets from Profectus BioSciences Inc USA for an upfront cash consideration of USD 11.29 million (around Rs 80 crore) with potential earn-outs on achieving certain milestones. Auro Vaccines LLC is a wholly-owned subsidiary of Aurobindo Pharma USA Inc, USA, which is a wholly-owned arm of the company, Aurobindo Pharma said in a filing to the BSE. The indicative time period for completion of acquisition of research and development assets of Profectus BioSciences Inc is first half of 2020, it added. The acqusition provides access to proprietary and innovative technology platforms for prophylactic use and therapeutic use along with global R&D center, Aurobindo Pharma said. The acquisition will lead to enhancement of research and development capabilities and expertise in developing newer vaccines from basic discovery research into FDA-approved product, it added. Shares

Updated On: 28 Nov 2019 | 8:02 PM IST

The aggregate domestic growth was 27.2 per cent in June quarter, compared with 4.6 per cent in FY18 and minus 8.8 per cent in June quarter last year

Updated On: 23 Oct 2018 | 10:00 PM IST

Five sub-schemes have been announced under the pharma development programme with the objective to reduce the cost of production by 20-25 per cent in bulk drug parks.

Updated On: 25 Jun 2018 | 7:38 PM IST

To win the battle of perception, the Indian pharma industry should focus on capital allocation choices and capability building

Updated On: 14 Sep 2017 | 10:39 PM IST